Antiviral activity of the purposing drugs

Common
name
Latin
name
Main
purpose
Противовирусная активность in vitro
Orthomyxo
Corona
Paramyxo
Filo
Retro
Picorna
Influenza A
H1N1
Corona
COV
Parainfl.
PIV
Resp.sync.
RSV
Measles
MEV
Nipah
NIV
Hendra
HEV
Newcastle
NDV
Ebola
EBOV
Marburg
MARV
HIV 1
HIV1
Entero
EV71
Hepatitis B
HBV
Coxsackie
CV
Polioma
EV/POV
Hydroxychloroquine
Hydroxychloroquinum
antimalarial
         
*
*
               
Nitazoxanide
Nitazoxanidum
anthelmintic
                         
Ivermectin
Ivermectinum
antimalarial
                           
Mefloquine
Mefloquinum
antimalarial
                           
Metformin
Metforminum
antidiabetic
                             
Licorin
Lycorinum
-
                             
Azithromycin
Azithromycinum
antibiotic
                             
Thapsigargin
Thapsigarginum
-
                             
Papaverine
Papaverinum
vasodilating
                             
Doxycycline
Doxycyclinum
antibiotic
                             
Antabuse
Disulfiramum
anti-alcohol

                           

About 20% of hospitalized patients with severe Covid-19 usually have secondary infections, and about half of the patients who died after hospitalization due to Covid-19 had secondary bacterial infections. In the light of this fact, the appointment of some antibiotics to seriously ill patients is justified, especially if they exhibit not only an antibacterial, but also an antiviral effect. These are, for example, azithromycin, doxycycline and salinomycin. The latter, however, is used only in veterinary medicine.